Related Experiment Video
Updated: Jul 1, 2026

07:17
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Chronic immune stimulation correlates with reduced phenylalanine turnover
G Neurauter1, K Schröcksnadel, S Scholl-Bürgi
1Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria.
Current Drug Metabolism
|September 11, 2008
Summary
Chronic inflammation can cause neuropsychiatric issues by affecting neurotransmitters. Interferon-gamma
Area of Science:
- Neuroimmunology
- Neuroscience
- Biochemistry
Background:
- Neuropsychiatric symptoms, including mood changes and depression, are prevalent in chronic inflammatory conditions like autoimmune diseases, infections, and cancer.
- The exact mechanisms underlying these symptoms are not fully understood.
- Pro-inflammatory factors impact both serotonergic and adrenergic neurotransmitter systems.
Purpose of the Study:
- To investigate the role of pro-inflammatory cytokine interferon-gamma in the biosynthesis and oxidative stability of 5,6,7,8-tetrahydrobiopterin (BH4).
- To explore the link between BH4 metabolism, catecholamine synthesis, and neuropsychiatric symptoms in chronic inflammation.
Main Methods:
- The study focuses on the biochemical pathways influenced by interferon-gamma.
- It examines the stimulation of 5,6,7,8-tetrahydrobiopterin (BH4) biosynthesis by interferon-gamma.
- It investigates the impact of reactive oxygen species on BH4 stability in macrophages.
Main Results:
- Interferon-gamma stimulates the production of 5,6,7,8-tetrahydrobiopterin (BH4), a crucial cofactor for neurotransmitter synthesis.
- Reactive oxygen species generated in macrophages under interferon-gamma influence can degrade BH4.
- This oxidative loss of BH4 may impair the biosynthesis of catecholamines (dopamine, epinephrine, norepinephrine).
Conclusions:
- Oxidative degradation of BH4 during chronic inflammation may disrupt adrenergic neurotransmitter pathways.
- This disruption could contribute to the neuropsychiatric symptoms observed in patients with chronic inflammatory disorders.
- Further research is needed to elucidate the precise role of BH4 metabolism in these conditions.